Virpax Pharmaceuticals, Inc. (VRPX) Stock Forecast
VRPX analyst forecast
as of October 21, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $3.00 average of analyst targets
- Upside to target
- +374,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
VRPX analyst ratings
1 analystsNumber of analysts at each rating.
VRPX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VRPX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VRPX beat in 4 of 11.
What analysts expect from VRPX
1 analysts cover Virpax Pharmaceuticals; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.00, 374,900.0% above the latest close of $0.00. Virpax Pharmaceuticals beat the EPS estimate in 4 of the last 11 quarters.
Related: VRPX income statement, VRPX key metrics, VRPX chart. See the VRPX stock overview for the latest quote and news.
VRPX forecast FAQ
What is Virpax Pharmaceuticals's price target?
The average analyst price target for Virpax Pharmaceuticals is $3.00, 374,900.0% above the latest close of $0.00.
Is Virpax Pharmaceuticals a buy, hold or sell?
Of 1 analysts covering Virpax Pharmaceuticals, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
Does Virpax Pharmaceuticals usually beat earnings estimates?
Virpax Pharmaceuticals reported EPS at or above the analyst estimate in 4 of the last 11 quarters.